Kapiva, an Ayurveda wellness brand, raised $60 million in a Series D funding round led by 360 ONE Asset and Vertex Growth. Existing investors, including Vertex Ventures Southeast Asia and India and 3one4 Capital, also participated.
Key Highlights
- Kapiva raises $60 million in Series D, led by 360 ONE Asset and Vertex Growth.
- Round includes primary capital infusion and secondary exits, while Fireside Ventures reportedly exits.
Fireside Ventures, an early investor, was able to exit the round after receiving $28 million in primary capital.
The company raised $10 million in September 2024 from OrbiMed Asia, Vertex Ventures, and 3one4 Capital. It has raised almost $90 million to date.
Kapiva intends to use the new funds for research and development, manufacturing improvements, and brand building. It also intends to broaden its health-tech platform, focusing on chronic condition management and personalized care.
The company now has an annual revenue run rate of around Rs 550 crore, up from about Rs 350 crore in FY25. According to the company, it has grown at a rate of more than 80 percent per year for the past three years. Its EBITDA remains slightly negative, but it is close to breakeven and expects to become profitable in the coming quarter.
Also Read: Plazza Raises $1.4 Mn Funding Led by All In Capital
Kapiva is an ayurvedic nutrition brand founded in 2015 by Ameve Sharma and Shrey Badhani. It offers natural and organic products in categories such as diabetes, hypertension, liver health, hormonal balance, wellness, energy, and sports nutrition.
The company sells through its own website, e-commerce channels, and physical retail locations. Its products are now available in approximately 40,000 stores throughout India.
Kapiva competes against Innovacare, Gynoveda, and Wellbeing Nutrition.
